The contaminant chemical NDMA in Zantac pills is a substance that could cause cancer of the: pancreas (pancreatic cancer), stomach, colon, rectum (rectal cancer), bladder, or kidney (renal cancer). On April 1, 2020, the FDA announced that it was requesting a Zantac recall due to the presence of NDMA in Zantac and all other medications containing ranitidine.
Even before this Zantac recall, our law firm is currently investigating possible Zantac cancer lawsuits for personal injury and wrongful death cases. Please feel free to contact us if you want help evaluating a Zantac case. This service is free, confidential, and there is no obligation.
For background, we suggest you may want to read this November 29, 2019 article, “Zantac FDA Warning In September 2019 Leads To Lawsuits For Patients Diagnosed With Cancer“, posted on our Drug Injury Watch blog.
For details about this Zantac recall and the chemical NDMA in Zantac pills you can look at this document, “FDA Requests Removal of All Ranitidine Products (Zantac) from the Market”, issued by the FDA on April 1, 2020.
[View article at original source]